Veterinaria
Facultad
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (16)
2023
-
Genome-based epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Spain: A prospective multicentre study
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2575-2582
2020
-
Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/ TGFβ1 after myocardial infarction
eLife, Vol. 9, pp. 1-30
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
2019
-
The impact of culturing the organ preservation fluid on solid organ transplantation: A prospective multicenter cohort study
Open Forum Infectious Diseases, Vol. 6, Núm. 6
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
2017
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21
WAF1/CIP1
) Degradation
PLoS Genetics, Vol. 10, Núm. 10
2013
-
Increase in gonorrhoea among very young adolescents, Catalonia, Spain, January 2012 to June 2013
Eurosurveillance, Vol. 18, Núm. 33
-
Lkb1 Loss Promotes Tumor Progression of BRAFV600E-Induced Lung Adenomas
PLoS ONE, Vol. 8, Núm. 6
2012
-
Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
Cell Death and Disease, Vol. 3, Núm. 1
-
Protein kinase C (PKC)ζ-mediated Gα q stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts
Journal of Biological Chemistry, Vol. 287, Núm. 10, pp. 7792-7802
2009
-
Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection. Constitutive COX-2 expression and cardioprotection
Journal of Molecular and Cellular Cardiology, Vol. 46, Núm. 2, pp. 160-168
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229